Impact of enhanced bowel preparation on complications and prognosis following colonoscopic polypectomy

Table 6 Pathological examination and follow-up, n (%)

Indicator	Conventional bowel preparation group (n = 65)	Enhanced bowel preparation group (n = 65)	P value
Pathological confirmation of malignancy	5 (7.7)	4 (6.2)	0.76
6-month recurrence rate	10.8% (7/65)	3.1% (2/65)	0.05
Late complications	2 (3.1)	0 (0.0)	0.10
Tumor marker levels (CA19-9)	35.2 ± 10.3	28.1 ± 8.5	0.02
Tumor marker levels (CEA)	4.8 ± 1.2	3.9 ± 0.9	0.04
Lymph node metastasis rate	12.3% (8/65)	7.7% (5/65)	0.32
Postoperative infection rate	7.7% (5/65)	3.1% (2/65)	0.10
Patient satisfaction with the pathological results	80.0% (52/65)	87.7% (57/65)	0.12